Enveric Biosciences News and Activities

Enveric Biosciences is a company listed under the stock ticker ENVB (US).

View the org chart displaying its 11 main executives

Most searched biographies at Enveric Biosciences

• Joseph Tucker, Chief Executive Officer and Director
• Michael Webb, Chairman of the Board
• Frank Pasqualone, Director

Create your alert
to follow the executive moves at Enveric Biosciences.

Enveric Biosciences has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Enveric Biosciences

• Enveric Biosciences to Present at and Participate in Panel Discussion at Sachs Associates 8th Annual Neuroscience Innovation Forum During “J.P. Morgan Week 2025” – Enveric Biosciences
• Enveric Biosciences to Present at and Participate in Panel Discussion at Sachs Associates 8th Annual Neuroscience Innovation Forum During “J.P. Morgan Week 2025” – Enveric Biosciences
• Enveric Biosciences Announces New U.S. Patents Supporting EVM301 Series and EVM201 Series Compounds – Enveric Biosciences
• Enveric Biosciences Preclinical Pharmacokinetic Studies of EB-003 Support Oral Bioavailability, Demonstrate Brain Penetration, and Show No Evidence of Hallucination-like Behavior – Enveric Biosciences
• Press Releases – Enveric Biosciences
• Enveric Biosciences Reports Third Quarter 2024 Financial and Corporate Results – Enveric Biosciences
• Enveric Biosciences Signs Out-Licensing Agreement with MycoMedica Life Sciences for EB-002 – Enveric Biosciences
• Enveric Biosciences Announces Broad Range of Patent Issuances – Enveric Biosciences
• Enveric Biosciences Announces Broad Range of Patent Issuances – Enveric Biosciences
• Enveric Biosciences Announces Positive Pharmacology and Safety Data for Lead Product, EB-003 – Enveric Biosciences
• View more press releases Close

Social media about Enveric Biosciences

• Enveric Biosciences on Wikipedia, Google News & Yahoo Finance
• Enveric Biosciences on LinkedIn, X (Twitter) & YouTube